Testing Community-Led Outreach Clinics to Improve Health in Rural Areas
How to cite
Fitzpatrick, Anne. 2025. "Testing Community-Led Outreach Clinics to Improve Health in Rural Areas." AEA RCT Registry. AEARCTR-0015003. https://doi.org/10.1257/rct.15003-2.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Access to high quality healthcare is a critical driver of human capital and a cornerstone of broader individual and societal well-being. In Uganda, rural access to health care and to essential medicines remains a persistent challenge; although 86% of Ugandans live in rural areas, only 15-20% of the country’s doctors work in those same areas, which contributes to poorer health outcomes among rural populations. Aside from a few irregular, one-day “mobile clinics” or sponsored medical missions, there are few resources in place for delivering healthcare on a regular basis to people in remote areas. We partnered with Health Access Connect (HAC), a Ugandan-based NGO that coordinates monthly, financially self-sustainable outreach visits by clinical staff from government health facilities to rural communities that are located at least 5 km away from public health facilities. Through a cluster-randomized trial in 64 health facilities and 192 villages, this study will evaluate the impact of HAC’s community-based outreach activities on the demand, quality, and utilization of health services, household health outcomes, child schooling and human capital, and household labor market incomes.
Intervention
The HAC program establishes one-day integrated care outreach clinics in remote communities (communities that are greater than 5 km from the nearest health facility) every 1-2 months. Government healthcare workers are transported from the health facility to target communities to provide a range of health services. Local Community Associations in remote communities are trained to lead the program in collaboration with the local health facility and are also supported in financing the costs of the outreach clinics.
Experimental design
This study is a two-armed randomized control trial that will be conducted among 64 health facilities, 192 corresponding communities / villages (3 villages per health facility) that are located within each health facility’s catchment area, and an estimated 3840 eligible households (approximately 20 households per selected village). The study consists of a baseline survey with health facilities, villages, and households, followed by randomization of health facilities into the HAC intervention and control arms and the implementation of the two-year family planning intervention. The endline survey will be conducted around one year after the implementation begins.
We will select 64 HC-III or HC-IV health facilities (HFs), and we will identify 128 villages (2 villages per HF) that are located more than 5 km away from the 64 HFs and another 64 communities (1 community per HF) that are located adjacent to (within 5km of) the 64 HFs. From each village/community, we will select 20 households with women aged 18–35 who are non-pregnant and at least six months postpartum for baseline surveys.
Following a baseline survey with 3840 households and 64 HFs, we will randomize HFs, and their corresponding villages and households, into a treatment group or a control group:
• 32 HFs will be randomly selected as the control group. These HFs, and their corresponding villages and households, will receive no interaction with the HAC intervention, and no HAC outreach services will take place.
• 32 HFs will be randomly selected as the treatment group. Staff at these HFs will partner with HAC and will provide outreach services to households in the corresponding villages that are part of the HF's service catchment area..
We will then follow up with the surveyed households and health facility one year after the intervention rollout to: (i) measure impacts of the HAC intervention on short-term outcomes of interest, specifically contraception, (ii) identify any effects of the HAC intervention on the service delivery at health facilities, (iii) detect any unintended impacts of the HAC intervention on service utilization at HFs and the resulting spillover effects that these unintended effects may have had on non-target communities, and (iv) estimate the cost-effectiveness of the HAC.
Design details
Cited by
No citation data available for this registration yet.